Sirnaomics-B Appoints New Chief Medical Officer and Chief Commercial Officer

Ribo Life Science-B (06938) announced that Dr. Anders Gabrielsen has been appointed as Chief Medical Officer and Dr. John Taylor as Chief Commercial Officer, effective from March 25, 2026.

Dr. Gabrielsen has over 20 years of experience in the field of cardiovascular, renal, and metabolic therapies, having held positions in clinical development and medical affairs at several internationally renowned pharmaceutical companies. Dr. Taylor brings more than 20 years of experience in the global biopharmaceutical industry, focusing on corporate business development.

In addition, Dr. Gan Liming will no longer serve as the Chief Medical Officer but will continue to serve as the Executive Director, Co-Chief Executive Officer, and President of Global R&D of the company.